T-regulatory cells protect against GVH disease after transplant

12/8/2009 | HemOnc Today

Acute leukemia patients administered with purified T-regulatory cells did not develop graft-versus-host disease after undergoing haploidentical, high-dose stem cell transplant, according to an Italian study. The technique could help reduce infection-related deaths linked to high-dose stem cell transplants, the researchers said.

View Full Article in:

HemOnc Today

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Santa Ana, CA
Regulatory Analyst
Delta Dental
Alpharetta, GA
Associate Director, Regulatory Affairs - Promotional Review
Novo Nordisk
Princeton, NJ
Eastern Zone Sales Director
Regenesis Biomedical
Multiple Locations, SL_Multiple Locations
Senior Financial Analyst - Growing Manager Care Health Org
Fallon Community Health Plan
Worcester, MA